| Jun 24 |
Alnylam reveals positive Phase III results for rare heart disease drug vutrisiran
|
| Jun 24 |
Tech sector growth, EU considers fining Apple: Morning Brief
|
| Jun 24 |
Alnylam Soars on Positive Heart-Drug Data
|
| Jun 24 |
HELIOS-B Shines Bright And Gives Alnylam Pharmaceuticals Another Blockbuster
|
| Jun 24 |
Alnylam Stock Pops on Surprising Results From a Key Heart Disease Drug
|
| Jun 24 |
Alnylam Stock Soars on Strong Results in Heart Drug Study
|
| Jun 24 |
Alnylam stock skyrockets on positive heart drug results
|
| Jun 24 |
Biggest stock movers today: Crypto stocks, AFRM, ALNY, and more
|
| Jun 24 |
Alnylam shares soar on positive data from its heart drug study
|
| Jun 24 |
Alnylam Soars After Drug Meets Goal in Heart Disease Trial
|
